Background. Existing task-specific practice interventions do not increase movement in stroke patients exhibiting minimal distal movement in the paretic upper extremity. Although often used, an important limitation of conventional electrical stimulation is that it does not involve task-specific practice. Objective. To determine the impact of an activity-specific electrical stimulation program on paretic limb impairment, functional limitation, and ability to perform valued activities in a subacute stroke patient exhibiting minimal paretic wrist and hand movement. Method. A female subject exhibiting trace paretic hand and finger movement was administered, 9 months after stroke, the upper extremity section of the Fugl-Meyer Impairment Scale (FM), the Action Research Arm Test (ARAT), and the Arm Motor Ability Test (AMAT). She then engaged in paretic upper extremity, task-specific training incorporating an electrical stimulation neuroprosthesis. Training occurred 3 hours per day, 5 days per week for 3 weeks. The FM, ARAT, and AMAT were again administered. Results. After intervention, she exhibited reduced impairment (evidenced by an FM score change of 22 to 29), decreased functional limitation (evidenced by an ARAT score change of 4 to 10), and increased ability and speed in performing valued AMAT activities. She also reported using the paretic hand and fingers more and new abilities to perform valued activities such as playing piano. Conclusion. Although conventional paretic upper extremity training strategies are ineffective in patients at this level, electrical stimulation training incorporating a neuroprosthesis appears promising.
N euromuscular electrical stimulation (NMES), used for decades for stroke motor rehabilitation, typically elicits paretic muscle contractions in an "on/off" manner. Increased paretic upper extremity range of motion and decreased spasticity are reported following surface NMES use. [1] [2] [3] [4] However, recent reviews 5, 6 note that conventional surface NMES does not produce functional changes, because patients do not volitionally activate their muscles (ie, participation is passive) and do not practice functional activities.
When repetitive, task-specific, paretic upper extremity practice (RTP) is provided to hemiparetic stroke patients, the size of cortical areas representing that upper extremity can increase and correlative functional changes can be seen. [7] [8] [9] Dettmers et al 10 recently reported that participation in a 3-hour/ day, for 20 weekdays, RTP training protocol reduced paretic upper extremity impairment and increased function. However, RTP regimens often require intensive therapist contact, restraint of the nonparetic upper extremity at home, and/or are not reimbursable. Participation in this regimen also required active finger and wrist extension, which constitutes a challenge for most stroke survivors.
To overcome the above-mentioned challenges, we administered 3-hour/day RTP to a subacute stroke patient (>3 to <12 months poststroke) exhibiting trace movement in her paretic wrist and fingers. Unlike conventional NMES, we incorporated an electrical stimulation orthosis that administered targeted stimulation while the subject performed valued activities. Thus, RTP was provided and assistance rendered via electrical stimulation when the subject experienced difficulty with certain activities, as reported in a recent successful pilot study by Alon et al. 11 This intervention was significant in that it was one of the first RTP programs attempted with a patient exhibiting only trace activity in finger and wrist movements.
Method Case Description
For this study, inclusion criteria were the following: (a) no active extension in the paretic wrist and fingers, (b) stroke experienced >3 months prior to study enrollment, (c) a score >70 on the Modified Mini-Mental State Examination, 12 (d) 6-second time, resulting in 3 seconds of sustained tetanic contraction that either open or close the hand.
Instruments
Our primary outcome measure was the upper extremity section of the Fugl-Meyer Scale (FM), 14 which assessed changes in upper extremity impairment. Specific FM items were derived from Brunnstrom's stages of poststroke motor recovery. Data arise from a 3-point ordinal scale (0 = cannot perform; 2 = can perform fully) applied to each item with a maximum score of 66. The FM has impressive test-retest reliability (total = .98-.99; subtests = .87-1.00), interrater reliability, and construct validity. 15, 16 To examine changes in functional limitation, we also administered the Action Research Arm Test (ARAT). 17 This 19-item test is divided into 4 categories (grasp, grip, pinch, and gross movement), with 16 items measuring the distal upper extremity. Items are graded on a 4-point ordinal scale (0 = can perform no part of the test; 3 = performs test normally) for a total possible score of 57. The ARAT has high intrarater (r = .99) and retest (r = .98) reliability and validity. 18, 19 Together, FM and ARAT detect motor changes in stroke, 20 but demonstration of changes in functional limitation or motor impairment alone is not sufficient to warrant clinical implementation of a new rehabilitation intervention. The Arm Motor Ability Test (AMAT) 21 was thus also used to determine changes in activity limitation. The AMAT is a 13-item test in which activities of daily living (ADLs) are rated according to a Functional Ability Scale (0 = does not perform with affected arm; 5 = does use arm at a level comparable to unaffected side) and a Quality of Movement Scale (0 = no movement initiated; 5 = normal movement). ADLs, further subdivided into components to be rated, include use of a knife and fork, eating with a spoon, combing hair, and tying shoelaces.
Testing and Intervention
All the above-mentioned outcome measures were administered during a 1-hour pretesting session occurring 1 week after consenting and screening had been completed (PRE). In a 2-hour session following pretesting the H-200 was fitted, and the subject was educated on device use by a research team member. This included proper donning/doffing and daily use of the device, including her exercises. During the next 5 weekdays, the subject completed 10 to 30 minutes of electrical stimulation at home to acclimatize to the electrical stimulation.
Every weekday over the next 3 weeks, the subject engaged in 3-hour therapy sessions in our research laboratory. The first 20 minutes of each session consisted of paretic upper extremity stretching and exercises, including wall push-ups, passive range of motion of supinator/pronator and wrist/digits into extension, and upper extremity weight bearing with wrist in extension. For the remainder of each therapy session, the subject used the H-200 for functional activities in 30-minute age >35 and <85 years, (e) only experienced 1 stroke, and (f) discharged from all physical rehabilitation. Exclusion criteria were the following: (a) participating in any experimental rehabilitation or drug studies; (b) pregnant; (c) uncontrolled seizure disorders; (d) excessive spasticity at the paretic elbow, wrist, or fingers, defined as a score of >3 on the Modified Ashworth Spasticity Scale; 13 and (e) excessive pain in the paretic upper extremity, as measured by a score >4 on a 10-point visual analog scale. Using these criteria, a volunteer who responded to an advertisement was recruited. She was the first individual to respond to the study advertisement.
Prior to screening and participation, the subject signed an informed consent form approved by the local institutional review board. The subject was a 54-year-old woman who had experienced, 9 months prior, a left frontal infarct extending into the basal ganglion. She was right-hand dominant, but reported not using the hand since the stroke. She received speech, occupational, and physical therapy immediately poststroke, 5 times per week, for 5 months. After a period of no therapy, the subject received occupational therapy, reflexology, acupuncture, and NMES, all at home during the month and a half prior to study enrollment. However, she reported no functional changes since outpatient therapy discharge. This was confirmed by observation of her medical records.
At enrollment, she was taking baclofen (10 mg, thrice daily) for paretic hamstring spasticity and warfarin (Coumadin) (12 mg/day). In addition to her stroke, the subject's medical history was significant for hemochromatosis and osteoporosis. She lived with her husband and received help for household chores and cooking. She ambulated independently without an ankle-foot orthosis or assistive device.
At screening, paretic upper extremity Modified Ashworth Spasticity Scale scores were 1 (elbow), 1+ (wrist), 1 (fingers), and 0 (thumb). The Modified Mini-Mental State Examination score was 100/100. There was no indication of upper limb contractures, and passive range of motion was normal without pain. Her nonparetic upper extremity exhibited normal range of motion and strength. She exhibited trace flexion and extension in her paretic wrist and fingers.
Apparatus
Bioness H-200 is a microprocessor-based, FDA-approved NMES device. Consisting of 3 sizes of forearm-hand molded orthosis, it contains an array of 5 surface electrodes ranging in size from 2 × 2 cm to 6 × 4 cm. Electrodes are positioned over the extensor digitorum, extensor pollicis brevis, flexor digitorum superficialis, flexor pollicis longus, and thenar muscles. Electrode positioning is custom determined for each patient to optimize contraction of fingers' flexors and extensors. Electrodes, connected to a stimulator, delivered alternating current at a carrier frequency of 11 kHz, time modulated to bursts at 36 Hz. The stimulator was set in an interrupted pulses mode with contraction and relaxation intervals set at 7 seconds "on" and 6 seconds "off." Two-second ramp up and ramp down were included in the The subject was now able to pick up a ball, stone, and different-sized blocks. AMAT scores at POST and POST-3 improved in functional ability, quality of movement, and time on 15 of 28 items. For example, open jar and wipe up spilled water tasks both showed marked increases as measured by AMAT.
Discussion
The subject exhibited changes in all outcome measures after intervention. The total FM score increased, with notable improvements in dynamic movement within upper extremity synergy and wrist stability/mobility. This finding was consistent with data from other NMES studies reporting impairment reductions as measured by the FM, 2,22 including a recent study using the same device used in this study. 11 Importantly, though, the current study enrolled a more impaired subject than previous NMES studies and used a neuroprosthesis (rather than conventional, cyclic NMES), suggesting efficacy for this modality in a broader band of subjects than previously believed.
The ARAT total score also increased markedly at POST, specifically changes noted in grasp and grip. This finding was also in accord with previous NMES research with less impaired subjects. 6 Given the distal focus of this intervention, an unexpected finding was that the subject did not demonstrate increased pinch ability. However, other studies 23 enrolling subjects at this impairment level have also not reported substantive distal changes, making this finding somewhat consistent with existing literature. We suspect that this protocol has a place in the therapy milieu, as it provides RTP that may act as a gateway to participation in other therapies. For example, the subject described herein now exhibits sufficient distal movement to participate in modified constraint-induced therapy, a reimbursable outpatient therapy requiring some distal movement. blocks, with the personal program shown in Table 1 . She completed three to five, 30-minute increments each session, and she consistently completed all 5 increments by weekday 9, equaling 2½ hours of functional electrical stimulation in the 3-hour session.
NMES was administered in a cyclic pattern for 6 seconds of stimulation and 6 seconds of rest for the entire duration of the session. During "on" times of stimulation, the subject engaged in repeated practice of specific functional tasks she identified during the fitting/education session (as shown in Table 2 ), stretching, or active range of motion activities.
The subject returned to the research laboratory 1 week after intervention to complete outcome tests. The same team member who administered the posttesting (POST) was blinded to whether the subject had participated in any intervention. This is because he frequently performed multiple tests on subjects for many studies, sometimes without an intervention taking place. He also administered the 3-month posttest (POST-3) on the subject in the same location and using the same measures as previously.
Results
The subject's movement ability was determined by comparing FM, ARAT, and AMAT scores obtained at PRE with those at POST and with those at 3 months after intervention (POST-3). Before intervention, the subject exhibited minimal isolated movement in the paretic limb, indicated with an FM score of 22 at PRE, reflecting low wrist stability/mobility and inability to perform most FM hand items. A score of 4 on the ARAT at PRE reflected the subject's limited grasp, grip, and pinch, as she was unable to pick up varying sizes of blocks and ball bearings. Scores on the AMAT at PRE (Table 3) reflected limited ability to demonstrate ADL tasks such as combing her hair and dressing.
After intervention, FM scores were 29 and 32 at POST and POST-3, respectively, with increases noted in wrist stability/mobility and new, partial movement in some isolated FM finger movements. Scores on ARAT were 10 at POST and POST-3, with notable changes on grasp and grip items. Table 3 AMAT Score Before and After Intervention AMAT scores revealed changes in functional ability and quality of movement, all in association with decreased time to complete tasks. The subject was better able to perform AMAT ADLs, such as bringing a fork or spoon to mouth, grasping and screwing a jar lid, and donning a T-shirt. New, valued abilities the subject reported after intervention included turning on light switches, striking individual piano keys, turning door knobs, and hugging her husband by lifting her paretic upper extremity to his shoulder. In performing these ADLs, she exhibited a more functional and natural pattern of movement, especially grasp and release of objects. Interestingly, some AMAT activities took longer to perform at the 3-month testing period. However, most of these activities were new activities that the subject could not previously perform, or those that she was now performing better. As such, although the time required to complete was sometimes slower, the fact that the subject could now perform the activity, or perform it better, was positive. An additional, interesting finding was increased paretic elbow movement, although it was not targeted. We were not surprised by this finding, given that the RTP in this study, although not targeting the elbow, necessarily incorporated repetitive elbow extension and flexion.
The findings suggest that application of an NMES orthosis in combination with RTP can result in significant functional outcomes, even with a subject exhibiting only trace movement in the paretic wrist and fingers. This is significant, given a paucity of efficacious therapies for this group of subjects. Because the subject improved on outcome measures in a relatively short time, was not receiving other therapies, and had exhibited a "plateau" for some time, changes are most likely attributable to the intervention described herein. Although a case study may be optimal for presenting specific detailed data, results often cannot be generalized to any given population. Thus, positive findings of this study warrant a larger trial, with a control group, to determine efficacy of NMES orthosis training in stroke.
